Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches

Within Plasma, revenues revenues grew 6% in the fourth quarter of fiscal 2024, driven primarily by disposable volume and software. The collections environment in the United States continued to be favorable, with disposables growing 4% in the quarter and 13% in fiscal 2024. Excluding the effects of the Consolidated Screening List's (CSL) U.S. Transitional supply agreement, the company's core plasma business is projected to deliver additional growth of 8% to 12% in fiscal 2025. Other Key Picks MEDP's earnings ...